Burden of diarrhea in the Eastern Mediterranean region, 1990-2013 : findings from the Global burden of Disease study 2013 by Uthman, Olalekan A. & HASH(0x5624fa8dff48)
  
 
 
 
warwick.ac.uk/lib-publications 
 
 
 
 
 
Original citation: 
GBD Collaborators (Including: Uthman, Olalekan A.). (2016) Burden of diarrhea in the 
Eastern Mediterranean region, 1990-2013 : findings from the Global burden of Disease study 
2013. American Journal of Tropical Medicine and Hygiene, 95 (6). 1319 -1329.  
 
Permanent WRAP URL: 
http://wrap.warwick.ac.uk/81351                            
 
Copyright and reuse: 
The Warwick Research Archive Portal (WRAP) makes this work by researchers of the 
University of Warwick available open access under the following conditions.  Copyright © 
and all moral rights to the version of the paper presented here belong to the individual 
author(s) and/or other copyright owners.  To the extent reasonable and practicable the 
material made available in WRAP has been checked for eligibility before being made 
available. 
 
Copies of full items can be used for personal research or study, educational, or not-for-profit 
purposes without prior permission or charge.  Provided that the authors, title and full 
bibliographic details are credited, a hyperlink and/or URL is given for the original metadata 
page and the content is not changed in any way. 
 
Publisher’s statement: 
© 2016 American Journal of Tropical Medicine and Hygiene  
https://doi.org/10.4269/ajtmh.16-0339  
A note on versions: 
The version presented in WRAP is the published version or, version of record, and may be 
cited as it appears here. 
 
For more information, please contact the WRAP Team at: wrap@warwick.ac.uk 
 
Am. J. Trop. Med. Hyg., 95(6), 2016, pp. 1319–1329
doi:10.4269/ajtmh.16-0339
Copyright © 2016 by The American Society of Tropical Medicine and Hygiene
Burden of Diarrhea in the Eastern Mediterranean Region, 1990–2013:
Findings from the Global Burden of Disease Study 2013
Ibrahim Khalil,1 Danny V. Colombara,1 Mohammad Hossein Forouzanfar,1 Christopher Troeger,1 Farah Daoud,1
Maziar Moradi-Lakeh,1,2 Charbel El Bcheraoui,1 Puja C. Rao,1 Ashkan Afshin,1 Raghid Charara,1 Kalkidan Hassen Abate,3
Mohammed Magdy Abd El Razek,4 Foad Abd-Allah,5 Remon Abu-Elyazeed,6 Aliasghar Ahmad Kiadaliri,7,8
Ali Shafqat Akanda,9 Nadia Akseer,10,11 Khurshid Alam,12,13,14 Deena Alasfoor,15 Raghib Ali,16 Mohammad A. AlMazroa,17
Mahmoud A. Alomari,18 Rajaa Mohammad Salem Al-Raddadi,19 Ubai Alsharif,20 Shirina Alsowaidi,21 Khalid A. Altirkawi,22
Nelson Alvis-Guzman,23 Walid Ammar,24 Carl Abelardo T. Antonio,25 Hamid Asayesh,26 Rana Jawad Asghar,27
Suleman Atique,28 Ashish Awasthi,29 Umar Bacha,30 Alaa Badawi,31 Aleksandra Barac,32 Neeraj Bedi,33 Tolesa Bekele,34
Isabela M. Bensenor,35 Balem Demtsu Betsu,36 Zulfiqar Bhutta,10,37 Aref A. Bin Abdulhak,38 Zahid A. Butt,39 Hadi Danawi,40
Manisha Dubey,41 Aman Yesuf Endries,42 Imad D. A. Faghmous,43 Talha Farid,44 Maryam S. Farvid,44,46 Farshad Farzadfar,47
Seyed-Mohammad Fereshtehnejad,48 Florian Fischer,49 Joseph Robert Anderson Fitchett,50 Katherine B. Gibney,51,52
Ibrahim Abdelmageem Mohamed Ginawi,53 Melkamu Dedefo Gishu,54,55 Harish Chander Gugnani,56,57 Rahul Gupta,58
Gessessew Bugssa Hailu,36,59 Randah Ribhi Hamadeh,60 Samer Hamidi,61 Hilda L. Harb,24 Mohammad T. Hedayati,62
Mohamed Hsairi,63 Abdullatif Husseini,64 Nader Jahanmehr,65 Mehdi Javanbakht,66 Tariku Jibat,67,68 Jost B. Jonas,69
Amir Kasaeian,47,70 Yousef Saleh Khader,71 Abdur Rahman Khan,44 Ejaz Ahmad Khan,72 Gulfaraz Khan,73
Tawfik Ahmed Muthafer Khoja,74 Yohannes Kinfu,75 Niranjan Kissoon,76 Ai Koyanagi,77 Aparna Lal,78
Asma Abdul Abdul Latif,79 Raimundas Lunevicius,80,81 Hassan Magdy Abd El Razek,82 Azeem Majeed,83
Reza Malekzadeh,84 Alem Mehari,85 Alemayehu B. Mekonnen,14,86 Yohannes Adama Melaku,87,88 Ziad A. Memish,89,90
Walter Mendoza,91 Awoke Misganaw,1 Layla Abdalla Ibrahim Mohamed,92 Jean B. Nachega,93,94 Quyen Le Nguyen,95
Muhammad Imran Nisar,96 Emmanuel Kwame Peprah,97 James A. Platts-Mills,98 Farshad Pourmalek,76 Mostafa Qorbani,99
Anwar Rafay,100,101 Vafa Rahimi-Movaghar,102 Sajjad Ur Rahman,103 Rajesh Kumar Rai,104 Saleem M. Rana,100,101
Chhabi L. Ranabhat,105,106 Sowmya R. Rao,107 Amany H. Refaat,40,108 Mark Riddle,109 Gholamreza Roshandel,84,110
George Mugambage Ruhago,111 Muhammad Muhammad Saleh,112 Juan R. Sanabria,113,114 Monika Sawhney,115
Sadaf G. Sepanlou,84 Tesfaye Setegn,116 Karen Sliwa,117 Chandrashekhar T. Sreeramareddy,118 Bryan L. Sykes,119
Mohammad Tavakkoli,120 Bemnet Amare Tedla,86,121 Abdullah S. Terkawi,122,123,124 Kingsley Ukwaja,125
Olalekan A. Uthman,126 Ronny Westerman,127,128 Mamo Wubshet,86,129 Muluken A. Yenesew,116 Naohiro Yonemoto,130
Mustafa Z. Younis,131 Zoubida Zaidi,132 Maysaa El Sayed Zaki,133 Abdullah A. Al Rabeeah,17 Haidong Wang,1
Mohsen Naghavi,1 Theo Vos,1 Alan D. Lopez,1,134 Christopher J. L. Murray,1 and Ali H. Mokdad1*
1Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington; 2Department of Community Medicine, Gastrointestinal
and Liver Disease Research Center, Iran University of Medical Sciences, Tehran, Iran; 3Jimma University, Jimma, Ethiopia; 4Aswan Faculty
of Medicine, Aswan, Egypt; 5Department of Neurology, Cairo University, Cairo, Egypt; 6GlaxoSmithKline, Philadelphia, Pennsylvania; 7Clinical
Epidemiology Unit, Orthopedics, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; 8Health Services Management Research
Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran; 9University of Rhode Island, Kingston,
Rhode Island; 10The Hospital for Sick Children, Toronto, Canada; 11University of Toronto, Toronto, Canada; 12Murdoch Children’s Research
Institute, Melbourne, Australia; 13University of Melbourne, Melbourne, Australia; 14University of Sydney, Sydney, Australia; 15Ministry of Health,
Al Khuwair, Oman; 16University of Oxford, Oxford, United Kingdom; 17Kingdom of Saudi Arabia Ministry of Health, Riyadh, Saudi Arabia;
18Division of Physical Therapy, Department of Rehabilitation Sciences, Jordan University of Science and Technology, Irbid, Jordan; 19Ministry
of Health, Jeddah, Saudi Arabia; 20Charité Universitätsmedizin, Berlin, Germany; 21Department of Internal Medicine, College of Medicine and
Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates; 22King Saud University, Riyadh, Saudi Arabia; 23Universidad de
Cartagena, Cartagena de Indias, Colombia; 24Ministry of Public Health, Beirut, Lebanon; 25Department of Health Policy and Administration,
College of Public Health, University of the Philippines, Manila, Philippines; 26Department of Medical Emergency, School of Paramedic, Qom
University of Medical Sciences, Qom, Iran; 27South Asian Public Health Forum, Islamabad, Pakistan; 28Graduate Institute of Biomedical
Informatics, Taipei Medical University, Taipei, Taiwan; 29Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India;
30School of Health Sciences, University of Management and Technology, Lahore, Pakistan; 31Public Health Agency of Canada, Toronto, Canada;
32Faculty of Medicine, University of Belgrade, Belgrade, Serbia; 33College of Public Health and Tropical Medicine, Jazan, Saudi Arabia;
34Madawalabu University, Bale Goba, Ethiopia; 35University of São Paulo, São Paulo, Brazil; 36Mekelle University, Mekelle, Ethiopia; 37Medical
Center, Aga Khan University, Karachi, Pakistan; 38University of Iowa Hospitals and Clinics, Iowa City, Iowa; 39Al Shifa Trust Eye Hospital,
Rawalpindi, Pakistan; 40Walden University, Minneapolis, Minnesota; 41International Institute for Population Sciences, Mumbai, India;
42Arba Minch University, Arba Minch, Ethiopia; 43London School of Hygiene and Tropical Medicine, London, United Kingdom; 44University
of Louisville, Louisville, Kentucky; 45Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts; 46Institute for
Health Policy, Boston, Massachusetts; 47Non-Communicable Diseases Research Center, Endocrinology and Metabolism Research Institute,
Tehran University of Medical Sciences, Tehran, Iran; 48Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm,
Sweden; 49Bielefeld University, Bielefeld, Germany; 50Harvard University, Boston, Massachusetts; 51Department of Epidemiology and Preventive
Medicine, Monash University, Melbourne, Australia; 52Melbourne Health, Parkville, Australia; 53College of Medicine, University of Hail, Hail,
Saudi Arabia; 54Haramaya University, Dire Dawa, Ethiopia; 55Kersa Health and Demographic Surveillance System, Harar, Ethiopia; 56Department
of Microbiology, Saint James School of Medicine, Anguilla, British West Indies; 57Department of Epidemiology and Biostatistics, Saint James
School of Medicine, Anguilla, British West Indies; 58West Virginia Bureau for Public Health, Charleston, West Virginia; 59Kilte Awlaelo Health
and Demographic Surveillance System, Ethiopia; 60Arabian Gulf University, Manama, Bahrain; 61Hamdan Bin Mohammed Smart University,
Dubai, United Arab Emirates; 62Department of Medical Mycology and Parasitology, School of Medicine, Mazandaran University of Medical
Sciences, Sari, Iran; 63Department of Epidemiology, Salah Azaiz Institute, Tunis, Tunisia; 64Qatar University, Doha, Qatar; 65Department of Public
Health, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 66University of Aberdeen, Aberdeen, United
Kingdom; 67Addis Ababa University, Debre Zeit, Ethiopia; 68Wageningen University, Wageningen, Netherlands; 69Department of Ophthalmology,
*Address correspondence to Ali H. Mokdad, Institute for Health
Metrics and Evaluation, 2301 5th Avenue, Suite 600, Seattle, WA
98121. E-mail: mokdaa@uw.edu
1319
Medical Faculty Mannheim, Ruprecht-Karls-University Heidelberg, Mannheim, Germany; 70Hematology-Oncology and Stem Cell Transplantation
Research Center, Tehran University of Medical Sciences, Tehran, Iran; 71Jordan University of Science and Technology, Irbid, Jordan;
72Health Services Academy, Islamabad, Pakistan; 73Department of Microbiology and Immunology, College of Medicine and Health Sciences,
United Arab Emirates University, Al Ain, United Arab Emirates; 74Executive Board of the Health Ministers’ Council for Cooperation Council
States, Riyadh, Saudi Arabia; 75Centre for Research and Action in Public Health, Faculty of Health, University of Canberra, Canberra, Australia;
76University of British Columbia, Vancouver, Canada; 77Research and Development Unit, Parc Sanitari Sant Joan de Deu (CIBERSAM),
Barcelona, Spain; 78Australian National University, Canberra, Australia; 79Department of Zoology, Lahore College for Women University, Lahore,
Pakistan; 80Aintree University Hospital, National Health Service Foundation Trust, Liverpool, United Kingdom; 81School of Medicine, University
of Liverpool, Liverpool, United Kingdom; 82Mansoura Faculty of Medicine, Mansoura, Egypt; 83Imperial College London, London, United
Kingdom; 84Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran; 85Howard University College of Medicine,
Washington, District of Columbia; 86University of Gondar, Gondar, Ethiopia; 87School of Public Health, Mekelle University, Mekelle, Ethiopia;
88School of Medicine, University of Adelaide, Adelaide, Australia; 89Saudi Ministry of Health, Riyadh, Saudi Arabia; 90College of Medicine,
Alfaisal University, Riyadh, Saudi Arabia; 91United Nations Population Fund, Lima, Peru; 92Federal Ministry of Health, Khartoum, Sudan;
93University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA; 94Stellenbosch University, Cape Town, Western Cape, South Africa;
95Institute for Global Health Innovations, Duy Tan University, Da Nang, Vietnam; 96Aga Khan University, Karachi, Pakistan; 97National Heart,
Lung, and Blood Institute, Bethesda, Maryland; 98University of Virginia, Charlottesville, Virginia; 99Department of Community Medicine,
School of Medicine, Alborz University of Medical Sciences, Karaj, Iran; 100Contech International Health Consultants, Lahore, Pakistan;
101Contech School of Public Health, Lahore, Pakistan; 102Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences,
Tehran, Iran; 103Hamad Medical Corporation, Doha, Qatar; 104Society for Health and Demographic Surveillance, Suri, India; 105Wonju College
of Medicine, Yonsei University, Wonju, South Korea; 106Institute for Poverty Alleviation and International Development, Yonsei University, Wonju,
South Korea; 107Department of Surgery, School of Medicine, Boston University, Boston, Massachusetts; 108Suez Canal University, Ismailia, Egypt;
109Naval Medical Research Center, Silver Spring, Maryland; 110Golestan Research Center of Gastroenterology and Hepatology, Golestan University
of Medical Sciences, Gorgan, Iran; 111Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania; 112Development Research
and Projects Center, Abuja, Nigeria; 113Department of Surgery and Comprehensive Cancer Center, Joan C. Edwards School of Medicine, Marshall
University, Huntington, West Virginia; 114Case Western Reserve University, Cleveland, Ohio; 115Marshall University, Huntington, West Virginia;
116Bahir Dar University, Bahir Dar, Ethiopia; 117Faculty of Health Sciences, Hatter Institute for Cardiovascular Research in Africa, University
of Cape Town, Cape Town, South Africa; 118Department of Community Medicine, International Medical University, Kuala Lumpur, Malaysia;
119Departments of Criminology, Law and Society, Sociology, and Public Health, University of California-Irvine, Irvine, California; 120Westchester
Medical Center, Valhalla, New York; 121James Cook University, Cairns, Australia; 122Department of Anesthesiology, University of Virginia,
Charlottesville, Virginia; 123Outcomes Research Consortium, Cleveland Clinic, Cleveland, Ohio; 124Department of Anesthesiology, King Fahad
Medical City, Riyadh, Saudi Arabia; 125Department of Internal Medicine, Federal Teaching Hospital, Abakaliki, Nigeria; 126Warwick Medical
School, University of Warwick, Coventry, United Kingdom; 127Federal Institute for Population Research, Wiesbaden, Germany; 128German
National Cohort Consortium, Heidelberg, Germany; 129Addis Continental Institute of Public Health, Addis Ababa, Ethiopia; 130Department
of Biostatistics, School of Public Health, Kyoto University, Kyoto, Japan; 131Jackson State University, Jackson, Mississippi; 132University Hospital,
Setif, Algeria; 133Faculty of Medicine, Mansoura University, Mansoura, Egypt; 134Melbourne School of Population and Global Health,
University of Melbourne, Melbourne, Australia
Abstract. Diarrheal diseases (DD) are leading causes of disease burden, death, and disability, especially in children
in low-income settings. DD can also impact a child’s potential livelihood through stunted physical growth, cognitive
impairment, and other sequelae. As part of the Global Burden of Disease Study, we estimated DD burden, and the
burden attributable to specific risk factors and particular etiologies, in the Eastern Mediterranean Region (EMR)
between 1990 and 2013. For both sexes and all ages, we calculated disability-adjusted life years (DALYs), which are
the sum of years of life lost and years lived with disability. We estimate that over 125,000 deaths (3.6% of total deaths)
were due to DD in the EMR in 2013, with a greater burden of DD in low- and middle-income countries. Diarrhea
deaths per 100,000 children under 5 years of age ranged from one (95% uncertainty interval [UI] = 0–1) in Bahrain
and Oman to 471 (95% UI = 245–763) in Somalia. The pattern for diarrhea DALYs among those under 5 years of age
closely followed that for diarrheal deaths. DALYs per 100,000 ranged from 739 (95% UI = 520–989) in Syria to 40,869
(95% UI = 21,540–65,823) in Somalia. Our results highlighted a highly inequitable burden of DD in EMR, mainly
driven by the lack of access to proper resources such as water and sanitation. Our findings will guide preventive and
treatment interventions which are based on evidence and which follow the ultimate goal of reducing the DD burden.
INTRODUCTION
Diarrheal diseases (DD) are a major cause of childhood
mortality globally, resulting in approximately 550,000 deaths
among children under 5 years of age each year.1 Although
mortality due to DD has declined significantly in children
over the past 20 years, the incidence of childhood diarrhea
in low-income countries (LICs) has not fallen appreciably.1
For those who survive these illnesses, repeated infections
by enteric pathogens in the early years of life can lead to
serious, lifelong health consequences such as environmen-
tal enteric dysfunction, growth faltering, impaired cognitive
development, reduced immune response to infection and
vaccinations, and death.2
Although a wide spectrum of bacterial, viral, and parasitic
pathogens are responsible for infectious diarrhea worldwide,
their etiologic contribution may vary depending on the geo-
graphic location of the study, study durations, or the popu-
lation sampled.3 In addition, variations in the reported
frequency of diarrhea may reflect the diagnostic tools used
rather than the actual incidence of each pathogen.4 Further-
more, coinfections are common and more than one pathogen
may be implicated in cases of diarrhea.
The Eastern Mediterranean Region (EMR) is home to
more than 500 million people, representing a diverse group
of 22 countries, including Arab states in north Africa, Gulf
nations, and countries in west Asia. EMR countries have
diverse historical backgrounds, political and social contexts,
and fiscal and cultural influences on their health-care sys-
tems. The region has wide variation in per capita gross
national product, ranging from a high of $134,420 in Qatar
to a low of $2,000 in Afghanistan.5 Such wide variation has
a major influence on overall health spending and results in
substantial health inequities both within and across countries.
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Furthermore, the region has witnessed long years of political
instability and conflicts, including the recent Arab Spring
uprising and conflicts in countries such as Syria and Yemen.
Many countries in the EMR achieved important suc-
cesses in the 1970s and 1980s with the support of the
United Nations International Children’s Emergency Fund
and the World Health Organization (WHO) through the
National Control of Diarrheal Diseases Project.6,7 For
example, Egypt’s program, which spanned from 1981 to
1991, was credited with significantly improving diarrheal
case management.8–10 However, over the last two decades,
the momentum has slowed.11 As of January 2016, rotavirus
vaccines have been introduced through national immuniza-
tion programs in only three (Djibouti, Republic of Sudan,
and Yemen) of 11 Gavi-eligible countries in the region.12
The perceived lack of urgency relative to the major politi-
cal and economic challenges facing the region has contrib-
uted to the current low level of awareness regarding the
remaining burden of diarrhea. To date, there remains a
lack of adequate research to address these diseases in many
EMR countries.
Our objective in this report is to establish the size of
the burden, distribution of pathogens, and risk factors
for diarrhea in children and adults in the EMR for 1990
through 2013.
MATERIALS AND METHODS
Study region. The EMR countries were grouped according
to per capita gross national income (GNI) into LICs (Islamic
Republic of Afghanistan [Afghanistan], Djibouti, Somalia,
Republic of Yemen [Yemen]); middle-income countries (MICs)
(Arab Republic of Egypt [Egypt], Islamic Republic of Iran
[Iran], Iraq, Jordan, Lebanon, Libya, Morocco, Pakistan,
Palestine, Sudan, Syrian Arab Republic [Syria], Tunisia);
and high-income countries (HICs) (Bahrain, Kuwait, Oman,
Qatar, Saudi Arabia, and the United Arab Emirates [UAE]).
We defined LICs as those having a per capita GNI of $1,045
or less, MICs as those with a per capita GNI between $1,046
and $12,735, and HICs as countries with per capita GNI
of $12,736 or greater.
Global burden of disease. The Global Burden of Disease
Study 2013 (GBD 2013) is a systematic, comprehensive
effort to quantify health loss from 306 causes of diseases and
injuries, 240 causes of death, and 79 risk factors by sex and
age groups between 1990 and 2013 for 188 countries. GBD
2013’s estimation process, including that for DD, has been
described in detail elsewhere.1 The burden of DD was mea-
sured in disability-adjusted life years (DALYs), the sum of
years of life lost due to premature death (YLLs) and years
lived with disability (YLDs). The methods used to calculate
each of these are summarized below.
Mortality. Cause-specific mortality estimates, including
those for DD, were modeled using a Bayesian ensemble
modeling process.13 Diarrhea mortality data included vital
registration and verbal autopsy sources. The modeling pro-
cess estimated the mortality rate due to diarrhea for both
genders from 1990 to 2013 for all age groups in every
country, and in subnational areas of some countries. Covar-
iates, such as improved water and sanitation sources, mal-
nutrition, and population density were considered. The
ensemble model approach allowed for a suite of models,
weighted by out-of-sample predictive validity, to inform the
final estimates.
Morbidity. As with mortality, morbidity is modeled at
every year, gender, age, and geographic location in the GBD
study. We used DisMod-MR 2.0, a Bayesian meta-regression
mixed effects model, to calculate morbidity. DisMod-MR
was originally developed for GBD 2010 to address statistical
challenges in estimating nonfatal health outcomes and syn-
thesizing sparse and heterogeneous epidemiological data.
It uses nonlinear mixed effects models that include country-
and study-level covariates to generate priors for increasingly
detailed geographic regions in an analytic cascade. Preva-
lence, incidence, recovery, and death are related in a series
of ordinary differential equations within DisMod-MR. Basi-
cally, it is a mathematical modeling technique that takes data
collected from different sources, corrects for inconsistencies,
and fills in gaps when data are incomplete, ultimately pro-
ducing estimates of disease burden by age, sex, and country.
A full description of DisMod-MR is available elsewhere.14–16
Diarrhea prevalence and incidence data from a system-
atic literature review and population-representative surveys
informed the meta-analytic model and estimates.
Etiologies. Diarrhea cases and deaths were attributed to
pathogens using a counterfactual approach. A systematic lit-
erature review on the proportion of diarrhea cases that test
positive for a set of pathogens is used in the DisMod-MR
framework to estimate the age, sex, year, and geographic dis-
tribution of diarrheal pathogens. The population-attributable
fraction (PAF) is used to parse the fraction of diarrhea cases
and deaths due to each pathogen. The PAF is calculated as
PAF ¼ proportion 1 ½1=odds ratio; ð Þ
Where “proportion” is the proportion of cases positive for
a pathogen and “odds ratio” (OR) is the odds of diarrhea
given pathogen detection. The ORs were derived from the
Global Enteric Multicenter Study (GEMS), a multisite
case-control study of moderate-to-severe diarrhea in children
under 5 years of age,17 using a mixed effects conditional
logistic regression model. With the exception of Pakistan,
where the ORs were calculated from a model including only
the Pakistan GEMS site, the ORs were calculated from a
model that included all GEMS sites.
Vibrio cholerae and Clostridium difficile were estimated
separately from the other pathogens in GBD. Cholera cases
were estimated using data from previous studies compared
with WHO case notification data to estimate underreporting.
Cholera deaths were estimated using case fatality data in
DisMod-MR. Since C. difficile is frequently associated with
hospital and health-care utilization, hospital incidence data
were modeled in DisMod-MR 2.0.
Risk factors. We also assessed diarrheal DALYs, YLLs,
and YLDs attributable to childhood stunting (below −2 stan-
dard deviations of the median height of a reference popula-
tion), suboptimal breastfeeding (nonexclusive breastfeeding
and discontinued breastfeeding), vitamin A deficiency, zinc
deficiency, and water, sanitation, and hygiene (WASH).
Data analysis. The average decrease in deaths, DALYs,
YLLs, and YLDs was calculated by subtracting the mean
estimate in 1990 from the mean estimate in 2013, divided by
23 years. All reported rates are per 100,000 persons and are
not age standardized. Uncertainty for deaths, DALYs, and
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attributable fractions in GBD were derived from 1,000 draws
of the variables used to estimate these outcomes. For exam-
ple, the ORs, pathogen prevalence among diarrhea cases,
and mortality rates are from normal or log-normal distri-
butions and were combined at the draw level to estimate
pathogen-specific diarrhea mortality. The 95% uncertainty
intervals (UIs) then are the 2.5 and 97.5 percentiles of these
estimates. This analysis was conducted using Stata/SE 13.1
(StataCorp LP, College Station, TX) and maps were gener-
ated using the ggplot218 package in R 3.2.2 (R Foundation
for Statistical Computing, Vienna, Austria).
RESULTS
Deaths. There were 128,024 (95% UI = 88,729–172,361)
diarrhea-related deaths in the EMR in 2013, with an over-
all rate of 21 diarrheal deaths per 100,000 persons (95%
UI = 14–28) (Table 1). The majority of these deaths occurred
among children under 5 years of age (68.9%) (88,172, 95%
UI = 52,794–129,711) and adults over 70 years of age
(11.9%) (15,278, 95% UI = 9,491–22,518). There were no
consistent differences in diarrhea deaths per 100,000 between
males and females (Supplemental Figure 1). There were
some exceptions to the general pattern of children under
5 years of age bearing the greatest burden. In Djibouti, in
the year 2000, diarrhea deaths per 100,000 were greater among
those over 70 years of age (680, 95% UI = 394–1,088) than
among those under 5 years of age (187, 95% UI = 84–332). In
neighboring Somalia, death rates were also higher for individ-
uals over 70 years of age versus individuals under 5 years
of age at each time point.
Graphs of diarrhea deaths per 100,000 demonstrated a
steady decrease from 1990 to 2013, with the most notable
declines among children under 5 years of age and individuals
≥ 70 years of age (Figure 1). For all ages, diarrhea death
rates decreased by an average of 2.39% deaths per 100,000
per year during this period. For those under 5, 5–14, 15–49,
50–69, and over 70 years of age, the average decrease in the
diarrheal death rate was 11.17%, 0.39%, 0.17%, 0.78%, and
4.96% per 100,000 per year, respectively. The 2013 diarrhea-
associated death rates were stratified by country and
per capita GNI (Figure 2). Diarrhea deaths per 100,000
children under 5 years of age ranged from one (95%
UI = 0–1), in Bahrain and Oman (HICs), to 471 (95%
UI = 245–763), in Somalia (a LIC) (Supplemental
Table 1). Among MICs, Pakistan (225, 95% UI = 144–315)
and Sudan (120, 95% UI = 61–189) had diarrhea death rates
in excess of their economic peers. Overall, diarrhea mortality
appeared to be related to per capita GNI rather than geo-
graphical location.
Years of life lost due to premature mortality. Nearly
9 million (8,935,214, 95% UI = 5,865,116–12,571,874) YLLs
were attributable to diarrhea in the EMR in 2013. Children
under 5 years of age bore the majority (84.5%) of this bur-
den (7,553,654, 95% UI = 4,517,051–11,112,683), and had a
rate of 10,361 (95% UI = 6,196–15,242) YLLs per 100,000.
Children under 5 years of age in Bahrain (57, 95% UI = 34–
88), Oman (59, 95% UI = 31–108) and Qatar (95, 95% UI =
53–167) experienced the lowest rates of YLLs per 100,000
in the region. On the other hand, children in Somalia
(40,238, 95% UI = 20,975–65,112) and Afghanistan (20,675,
95% UI = 11,160–31,515), two countries with the longest
history of ongoing civil wars in the region, experienced the
highest rates.
Years lived with disability. Diarrhea was responsible for
a total of 1,002,096 (95% UI = 673,662–1,392,552) YLDs
in 2013 in the region, with children under 5 years of age
contributing more than half of this burden (586,935, 95%
UI = 391,944–820,782). The rate of YLDs per 100,000 among
children under 5 years of age was 805 (95% UI = 538–1,126)
and ranged from 177 (95% UI = 106–263) in Djibouti to 974
(95% UI = 662–1,357) in Afghanistan.
Disability-adjusted life years. Nearly 10 million DALYs
were attributable to diarrhea (9,937,310, 95% UI = 6,802,456–
13,650,080), with an overall rate of 1,610 (95% UI = 1,102–
2,212) DALYs per 100,000 in the EMR in 2013 (Table 2).
The majority of DALYs were borne by those under 5 years
of age (81.9%) (8,140,589, 95% UI = 5,082,597–11,726,801)
and those 15–49 years of age (7.4%) (737,925, 95% UI =
498,093–1,058,052). There were no consistent differences in
diarrhea-associated DALYs between males and females.
The average decrease in the number of DALYs over this
time period in the region as a whole was 568,035 per year,
with the majority of this decrease among those under 5 and
5–14 years of age (543,789 and 23,734 DALYs per year,
respectively). The pattern for diarrhea DALYs among those
under 5 years of age closely followed that for diarrheal
deaths. DALY rates ranged from 739 (95% UI = 520–989) in
Syria to 40,869 (95% UI = 21,540–65,823) in Somalia.
In each country, diarrhea DALYs decreased over time and
children under 5 years of age consistently contributed the
majority of diarrheal DALYs (Supplemental Figure 2).
Etiologies. The proportion of deaths attributable to spe-
cific etiologies in 2013, excluding cholera and C. difficile,
are presented in Figure 3. Generally, rotavirus infection
was the largest contributor to the diarrheal burden of dis-
ease. However, Shigella was the greatest contributor to diar-
rheal deaths and DALYs in Sudan. When also considering
cholera and C. difficile, the total proportion of attributable
deaths was greater than 100% (more than one attributable
TABLE 1
Diarrheal disease-associated deaths in the EMR, 2013
Age
(years) Sex Deaths (UI) Rate* (UI) % of total†
All ages Male 64,690 (38,893–95,066) 20 (12–30) 3.29
Female 63,334 (38,706–92,897) 21 (13–31) 3.88
Total 128,024 (88,729–172,361) 21 (14–28) 3.56
< 5 Male 44,346 (20,941–72,951) 118 (56–195) 11.19
Female 43,826 (21,668–71,417) 124 (61–201) 12.70
Total 88,172 (52,794–129,711) 121 (72–178) 11.90
5–14 Male 2,484 (1,113–4,690) 4 (2–7) 4.68
Female 3,105 (1,467–5,590) 5 (2–9) 7.17
Total 5,589 (3,175–9,011) 4 (2–7) 5.80
15–49 Male 4,634 (2,381–7,942) 3 (1–5) 1.14
Female 4,878 (2,537–8,189) 3 (2–5) 1.81
Total 9,512 (5,765–14,738) 3 (2–4) 1.41
50–69 Male 5,091 (2,584–8,884) 15 (8–27) 0.97
Female 4,383 (2,105–7,859) 13 (6–24) 1.13
Total 9,474 (5,487–15,012) 14 (8–23) 1.04
70+ Male 8,136 (4,253–13,493) 106 (55–175) 1.38
Female 7,142 (3,800–12,096) 83 (44–140) 1.22
Total 15,278 (9,491–22,518) 94 (58–138) 1.30
EMR = Eastern Mediterranean Region; UI = uncertainty interval.
*Rate is per 100,000.
†Percent of total deaths in the EMR for the specified age group and sex.
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pathogen per diarrheal episode) for Jordan, Palestine, Syria,
Bahrain, and Oman (Supplemental Figure 3). These same
five countries also had a relatively large proportion of diar-
rheal deaths attributed to cholera in 2013 and an increasing
cholera burden in the recent years (Supplemental Figure 4).
Graphs of the relative proportions of known etiologies lead-
ing to diarrheal DALYs for children under 5 years of age are
provided in Supplemental Figure 5.
Risk factors. In 2013, the two risk factors that con-
tributed to the greatest number of diarrhea-attributable
deaths (Supplemental Figure 6) and DALYs (Supplemen-
tal Figure 7) among those under 5 years of age were
WASH and suboptimal breastfeeding. Rates of suboptimal
breastfeeding–related deaths ranged from zero (0, 95%
UI = 0–1) in Bahrain and Oman to 232 (95% UI = 105–
405) in Somalia. The same pattern was seen with rates of
WASH-related deaths, where Bahrain and Oman had a
rate of one (95% UI = 0–1) and Somalia’s rate was 457
(95% UI = 238–734). WASH-related deaths and DALYs
were somewhat greater in LICs, and the burden due to
FIGURE 1. Diarrheal disease-associated deaths in the Eastern Mediterranean Region, 1990–2013.
FIGURE 2. Diarrheal disease-associated death rates among children under 5 years of age in the Eastern Mediterranean Region, sorted by low,
middle, and high income per capita gross national income, 2013.
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suboptimal breastfeeding was generally greater in HICs
(Supplemental Figures 8 and 9).
DISCUSSION
We reported the most comprehensive assessment of DD
burden and the contributions of specific pathogens and risk
factors in the EMR to date. In 2013, the estimated diarrhea-
associated deaths and DALYs were more than 125,000 and
nearly 10 million, respectively. We also found substantial var-
iation within the region, with LICs and MICs experiencing
social unrest bearing the vast majority of diarrheal burden.
Our estimates are comparable with others from recent
publications. A systematic literature review published in
2008 estimated diarrhea deaths among those under 5 years
of age in 13 EMR countries (Bahrain, Cyprus, Iran, Jordan,
Kuwait, Lebanon, Libya, Oman, Qatar, Saudi Arabia, Syria,
Tunisia, and the UAE) to be 12,000 (UI = 10,000–14,000),
and in nine other EMR countries (Afghanistan, Djibouti,
Egypt, Iraq, Morocco, Pakistan, Somalia, Sudan, and Yemen)
to be 221,000 (UI = 190,000–250,000).19 Our estimated num-
ber of DD-associated deaths in this age group, which com-
bines these two subregions, was similar. In addition, although
we did not follow the same grouping of countries in our
FIGURE 3. The proportion of diarrheal deaths due to known pathogens,* among children under 5 years of age in the Eastern Mediterranean
Region, 2013 (*excluding cholera and Clostridium difficile).
TABLE 2
Diarrheal disease-associated DALYs in the Eastern Mediterranean Region, 2013
Age
(years) Sex DALYs (UI) Rate* (UI) % of total†
All ages Male 5,003,063 (2,917,614–7,527,475) 1,575 (918–2,369) 4.51
Female 4,934,247 (2,959,335–7,385,260) 1,648 (988–2,466) 5.14
Total 9,937,310 (6,802,456–13,650,080) 1,610 (1,102–2,212) 4.80
< 5 Male 4,110,927 (2,083,037–6,565,118) 10,979 (5,563–17,533) 11.50
Female 4,029,662 (2,105,785–6,409,279) 11,363 (5,938–18,073) 12.97
Total 8,140,589 (5,082,597–11,726,801) 11,166 (6,971–16,085) 12.19
5–14 Male 267,327 (148,924–452,243) 400 (223–678) 3.33
Female 306,681 (169,331–506,004) 486 (268–802) 4.45
Total 574,008 (367,111–863,442) 442 (283–665) 3.84
15–49 Male 363,936 (223,641–561,754) 211 (130–326) 0.96
Female 373,988 (224,349–577,646) 235 (141–363) 1.16
Total 737,925 (498,093–1,058,052) 222 (150–319) 1.05
50–69 Male 158,484 (87,613–261,122) 476 (263–785) 0.78
Female 134,679 (72,309–228,946) 407 (219–692) 0.80
Total 293,163 (182,407–446,130) 442 (275–672) 0.79
70+ Male 102,390 (57,014–165,506) 1,330 (741–2,150) 1.15
Female 89,236 (51,181–142,531) 1,035 (593–1,652) 1.01
Total 191,626 (124,949–275,176) 1,174 (765–1,686) 1.08
DALY = disability-adjusted life years; EMR = Eastern Mediterranean Region; UI = uncertainty interval.
*Rate is per 100,000.
†Percent of total DALYs in the EMR for the specified age group and sex.
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study, the countries for which we estimated the highest diar-
rhea burden were all included in the “high-mortality” coun-
tries according to the study. In addition, a 2013 publication
estimated the number of DD-associated deaths in the EMR
among children under 5 years of age in 2011 to be 96,000
(UI = 64,200–153,300).20 This is comparable to our finding of
88,172 (UI = 52,794–129,711) and suggests a slight increase
in the number of deaths.
Our data clearly illustrated the gross health inequity in the
region, with HICs experiencing a nominal diarrhea burden
compared with the substantial burden in all LICs and some
MICs. However, what cannot be observed in our data are
the potential inequities in access to infrastructure and ser-
vices within individual countries of the EMR. Not only do
wealthier and urban communities have better access to
proper infrastructure for water and sanitation, they also tend
to have the education and financial resources to properly
use point-of-use water treatment modalities. Furthermore,
the introduction of vaccines against diarrheal pathogens may
exacerbate inequalities in diarrhea burden. For example,
although rotavirus infection was the largest contributor to
the diarrheal burden of disease, in some countries in the
region, rotavirus vaccine is only available in the private mar-
ket. This means that wealthier families, who have less need
for the vaccine, will gain the primary benefit from its avail-
ability. This is troubling because economic analyses of rota-
virus vaccine introduction among a number of EMR countries
have uniformly suggested that vaccine introduction would be
cost-beneficial from a societal perspective.6,21–23 One study
in Somalia (the only LIC country) suggested that introduc-
tion of a rotavirus as special immunization program during a
complex humanitarian emergency would meet WHO cost-
effectiveness benchmarks.24
A unique contribution of this analysis is the inclusion
of all age groups. Due to the high disease burden in young
children, nearly all diarrhea interventions and most diar-
rhea burden studies are limited to those under 5 years of
age.19,20,25 However, the burden among those over 70 years
of age is substantial, with DD-associated deaths totaling
nearly one-sixth of the number among those under 5 years
of age. The elderly may face increased diarrhea risk due to
immunosenescence and comorbidities, which may also neces-
sitate special consideration in their treatment.26 The increas-
ing nature of cholera burden in five EMR countries (Jordan,
Palestine, Syria, Bahrain, and Oman) is a cause of concern,
as neighboring countries remain at a high risk of transmis-
sion due to presence and movement of refugee populations
among them.
We found no systematic difference in under-5 diarrhea
deaths or DALYs when comparing females to males. We
hypothesized that there may exist evidence of differential
diarrhea mortality burden by sex. A previous analysis of
global demographic and health survey (DHS) data reported
that girls 1–4 years of age, particularly in the Middle Eastern
crescent, are at a mortality disadvantage compared with
boys,27 perhaps due to differences in health-care access and
nutritional status. Furthermore, an Egyptian study found
some evidence that, even when parents sought care for their
daughters with diarrhea, regional health-care providers pro-
vided biased treatment in favor of boys.28 However, more
recent publications, such as a 2009 verbal autopsy study in
Iraq, found no difference in under-5 mortality by sex.29
Our study has several limitations and strengths. First,
while our modeling process seeks to make use of all avail-
able data, the number of relevant publications in the region
is limited and unbalanced between countries. However, our
hierarchical modeling approach allows us to “borrow” strength
across time and geography to generate the best possible esti-
mates. Second, since we only account for the acute phase of
diarrhea in our YLD estimates, the resulting DALYs severely
underestimate diarrhea-associated morbidity. In GBD 2016,
we expect to include long-term sequelae such as stunting and
cognitive impairment,30,31 which will better estimate the true
burden of disease. Third, the reported distribution of diarrhea
etiologies was based on traditional laboratory detection tech-
niques,17 which may be less sensitive and specific than molec-
ular methods. For this reason, our future GBD estimates
will incorporate a GEMS reanalysis based on standardized
quantitative polymerase chain reaction data for all patho-
gens.32 Despite these limitations, this analysis also has several
strengths. GBD methodology ensures internal consistency
so that morbidity and mortality cannot be simultaneously
ascribed to competing causes and allows for comparability
between countries and across regions.
CONCLUSIONS
Although there were substantial improvements in DD-
related morbidity and mortality, the health inequities revealed
in our data show that more action is needed to reduce the bur-
den of diarrhea in the EMR, especially in lower-income coun-
tries and countries experiencing political and social unrest.
A coordinated approach that involves prevention and treat-
ment is needed to address the multiple causes of DD. Regional
health systems need to be strengthened to achieve the wide-
spread availability and use of oral rehydration salts, improved
rates of breastfeeding, improved nutrition, better sanitation
and hygiene, and increased coverage of measles immunization.
Due to the high relevance of rotavirus infections in EMR,33
there is also an urgent need to roll out rotavirus vaccine in
the region through government immunization programs that
would ensure access for the children who are most in need.
In addition, regional governments should begin deliberation
to integrate Shigella, enterotoxigenic Escherichia coli, and
other diarrheal vaccines that are currently in preclinical and
clinical trials into their expanded programs on immunization
as soon as they are approved and licensed.
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